We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Repair Therapy for Mitral Heart Valve

By HospiMedica staff writers
Posted on 19 Oct 2005
New repair therapy is designed to treat the leaky mitral valve of patients suffering from congestive heart failure.

The GeoForm annuloplasty ring, developed by Edwards Lifesciences Corp. More...
(Irvine, CA, USA), features a unique, three-dimensional shape shown to successfully treat mitral valve regurgitation, a backflow of blood caused by a leaking valve, the result of cardiomyopathy.

In a presentation at the annual meeting of the European Association for Cardio-Thoracic Surgery (EACTS) in Barcelona (Spain) in September 2005, Steven F. Bolling, M.D., presented results from a prospective study of 16 congestive heart failure patients, all of whom were suffering from mitral valve regurgitation due to the distortion of their heart's left ventricle.

Six months after their valves were surgically repaired with the GeoForm annuloplasty ring, their mitral valve regurgitation was eliminated and the left ventricle was reformed. Dr. Bolling is professor of surgery at the University of Michigan Health System (Ann Arbor, USA). He helped develop the GeoForm ring, along with Prof. Ottavio M. Alfieri, M.D., of St. Raffaele Hospital (Milan, Italy).

"While still early, these results clearly demonstrated excellent outcomes for patients suffering from severe mitral valve regurgitation and left ventricular dysfunction,” said Dr. Bolling. "We believe this heart valve ring will help break the cycle of mitral valve regurgitation and left ventricular distortion that can be caused by certain forms of congestive heart failure.”

Patients suffering from severe mitral valve regurgitation are five times more likely to die of a heart problem and six times more likely to have heart failure or some other serious cardiac problem than a healthy person.




Related Links:
Edwards Lifesciences

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology System
Riviera SPV AT
Infant Resuscitator
Easypuff
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.